glucose, (beta-d)-isomer has been researched along with Constriction, Pathological in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Jandeleit-Dahm, K; Peter, K | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Constriction, Pathological
| Article | Year |
|---|---|
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability.
Topics: Animals; Benzhydryl Compounds; Constriction, Pathologic; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Glucosides; Humans; Hypoglycemic Agents; Mice; Plaque, Atherosclerotic; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2022 |